scout

Special Issues

Contemporary Oncology®: Biomarkers, Pathways, and Targeted Therapies® - January 2024

Contemporary Oncology®: Biomarkers, Pathways, and Targeted Therapies® - January 2024

Volume: 1
Issue: 1
Oncology Live Urologists in Cancer Care®: July 2023

Oncology Live Urologists in Cancer Care®: July 2023

Volume: 1
Issue: 1
Oncology Live Urologists in Cancer Care®: August 2022

Oncology Live Urologists in Cancer Care®: July 2022

Volume: 1
Issue: 1
IO - Immuno-Oncology - July 2022 Issue

IO - Immuno-Oncology - July 2022 Issue

Volume: 1
Issue: 1
Contemporary Oncology®: Biomarkers, Pathways, and Targeted Therapies® - May 2022

Contemporary Oncology®: Biomarkers, Pathways, and Targeted Therapies® - May 2022

Volume: 1
Issue: 1
April 2022

Oncology Business News®: April 2022

Volume: 1
Issue: 1
SABCS 2019: Updates in HER2+ Breast Cancer

SABCS 2019: Updates in HER2+ Breast Cancer

Volume: 1
Issue: 1
Emerging MOAs in Multiple Myeloma: Updates From the 17th IMW

Emerging MOAs in Multiple Myeloma: Updates From the 17th IMW

Volume: 1
Issue: 1
August 2019

August 2019

Volume: 8
Issue: 4
Developments in NRG1 Fusion+ Cancers

Developments in NRG1 Fusion+ Cancers

Volume: 1
Issue: 1
June 2019

June 2019

Volume: 8
Issue: 3
Therapeutic Advances in Hairy Cell Leukemia

Therapeutic Advances in Hairy Cell Leukemia

Volume: 1
Issue: 1
The Changing Chronic Lymphocytic Leukemia Treatment Paradigm

The Changing Chronic Lymphocytic Leukemia Treatment Paradigm

Volume: 1
Issue: 1
Management of Diarrhea in Breast Cancer

Management of Diarrhea in Breast Cancer

Volume: 1
Issue: 1
Updates in Next-Generation Sequencing

Updates in Next-Generation Sequencing

Volume: 1
Issue: 1
April 2019

April 2019

Volume: 8
Issue: 2
 The Role of Folate Receptor Alpha in the Treatment of Ovarian Cancer

The Role of Folate Receptor Alpha in the Treatment of Ovarian Cancer

Volume: 1
Issue: 1
Therapeutic Developments in Acute Myeloid Leukemia

Therapeutic Developments in Acute Myeloid Leukemia

Volume: 1
Issue: 1
February 2019

February 2019

Volume: 8
Issue: 1
Focus on Pathways: Inhibition of the BCL-2 Pathway in Hematologic Malignancies

Focus on Pathways: Inhibition of the BCL-2 Pathway in Hematologic Malignancies

Volume: 1
Issue: 1
ASCO 2019: Therapeutic Updates in Melanoma

ASCO 2019: Therapeutic Updates in Melanoma

Volume: 1
Issue: 1
Focus on Pathways: Historical Perspective and Current Considerations in Hairy Cell Leukemia

Focus on Pathways: Historical Perspective and Current Considerations in Hairy Cell Leukemia

December 2018

December 2018

Volume: 7
Issue: 6
FGFR Inhibition in Cholangiocarcinoma: Update from the 2018 ESMO Congress

FGFR Inhibition in Cholangiocarcinoma: Update from the 2018 ESMO Congress

Volume: 1
Issue: 1
October 2018

October 2018

Volume: 7
Issue: 5
The Rationale for Bruton Tyrosine Kinase Inhibition in B-Cell Lymphomas

The Rationale for Bruton Tyrosine Kinase Inhibition in B-Cell Lymphomas

August 2018

August 2018

Volume: 7
Issue: 4